Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2296 of 5804
-
Real-World study tracks Efgartigimod's impact on myasthenia gravis symptoms
Disease control Recruiting nowThis study aims to generate real world evidence (RWE) from Italian clinical practice on the impact of efgartigimod alfa in gMG patients encompassing clinical outcomes and patient reported experiences. The study population will consist in adult patients with a documented diagnosi…
Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a keto diet help slow kidney disease? new study seeks answers
Disease control Recruiting nowThis is a 16 week pilot study of the impact of a nutritionist led ketogenic diet (Ren-Nu) supplemented with the medical food KetoCitra on autosomal dominant polycystic kidney disease.
Phase: NA • Sponsor: Richard Fatica • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a stick help you quit smoking? new study tests it in lung cancer patients
Symptom relief Recruiting nowThis clinical trial evaluates the feasibility of a novel tobacco cessation resource called a Buckeye Quit Stick among smokers with a diagnosed or suspected thoracic cancer. Tobacco use is the single most preventable cause of disease, disability, and death in the United States. Wh…
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New keyhole surgery could ease back pain and speed recovery
Symptom relief Recruiting nowLumbar spinal stenosis is a condition that can cause pain, sensory disturbances, and motor deficits due to the compression of neural structures in the lumbar spine. While conservative treatments such as physical therapy and pain management can help some patients, others with pers…
Sponsor: TecSalud Investigación Clínica • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Gel and bone graft combo aims to regrow Gum-Damaged bone
Disease control Recruiting nowOver the last 30 years, the prevalence of periodontitis (PE) has increased substantially, including among younger populations, highlighting the need to improve the management of this condition as a chronic disease and to develop techniques that favor its control and stability in …
Phase: NA • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New 'camera on a wire' gives doctors a live inside look at brain aneurysms
Diagnosis OngoingThis is an investigational study for a new medical device called the nOCT (neuro optical coherence tomography) Imaging System, which is manufactured by Spryte Medical, LLC. The nOCT Imaging System takes pictures from inside a blood vessel in your brain. These pictures give your d…
Phase: NA • Sponsor: Spryte Medical • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
New study tests monthly shot to help people stop using fentanyl
Disease control Recruiting nowThe goal of this clinical trial is to compare buprenorphine formulations (sublingual buprenorphine versus long-acting injectable buprenorphine) for treating opioid use disorder among individuals who use fentanyl and/or other high potency synthetic opioids. Individuals aged 18-65 …
Phase: EARLY_PHASE1 • Sponsor: Rachel R. Luba • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a simple survey speed up care for advanced cancer patients?
Symptom relief Recruiting nowThis study is testing whether electronic surveys can help patients with advanced cancer report their symptoms and care needs so their doctors can connect them to palliative/supportive care services sooner. The goal is to see if this approach can make it easier for patients to get…
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Stroke recovery at home: new telerehab study tests feasibility
Symptom relief Recruiting nowStroke is a major cause of motor disability, particularly hemiplegia, and its incidence is increasing as the population ages. Despite partial spontaneous recovery in the first three months, 80% of patients retain a motor deficit after six months, requiring intensive rehabilitatio…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Heart attack survivors may get Anti-Inflammatory boost from diabetes drug
Disease control Not yet recruitingThe goal of this clinical trial is to learn if dapagliflozin, a sodium-glucose cotransporter 2 inhibitor (SGLT2i), can reduce coronary artery inflammation in people with acute coronary syndrome (ACS) who do not have diabetes or heart failure. Coronary inflammation will be measur…
Phase: PHASE4 • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Sound waves may wake up immune system against liver tumors
Knowledge-focused Recruiting nowThis study is an investigator-initiated, randomized controlled trial enrolling patients with colorectal liver metastases. The objectives are to evaluate the safety and efficacy of contrast-enhanced ultrasound (CEUS)-mediated sonoporation as a potential therapeutic intervention an…
Phase: NA • Sponsor: Zealand University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Nurse-Led video program shows promise for diabetes control in thailand
Disease control CompletedThis randomized controlled trial aims to develop and evaluate a telenursing-based Diabetes Self-Management Education and Support (DSMES) program with uncontrolled type 2 diabetes mellitus in Thailand. The program is designed to improve diabetes self-management through nurse-led e…
Phase: NA • Sponsor: Chiang Mai University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New pill shows promise in early trial for Hard-to-Treat breast cancer
Disease control Recruiting nowThis is a first-in-human, open-label, Phase 1 study evaluating BBI-940, an investigational kinesin oral molecular degrader, administered as monotherapy or in combination with fulvestrant in adults with advanced or metastatic breast cancer.
Phase: PHASE1 • Sponsor: Boundless Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Gut health breakthrough? postbiotics may ease ADHD symptoms in kids
Symptom relief ENROLLING_BY_INVITATIONThe study aims to evaluate whether postbiotics supplementation can improve ADHD symptoms, such as mood and sleep, in children. Furthermore, salivary biochemical profiles will be analyzed and dietary habits will be recorded to further explore the effects and mechanisms of action o…
Phase: NA • Sponsor: I-Ching Chou • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
AI tool aims to predict heart risks in rare blood disorder patients
Knowledge-focused Not yet recruitingThis study employs a dual-cohort design to develop and validate a prognostic model for Major Adverse Cardiovascular Events (MACE) following revascularization in immune thrombocytopenia (ITP) patients with Coronary Artery Disease (CAD). The model will be developed and trained usin…
Sponsor: Xiao Hui Zhang • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Lupus drug continuation trial offers hope for disease control
Disease control Recruiting nowThe purpose of this study is to allow the continued administration of Deucravacitinib in participants with Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) who have completed study IM011074 or Study IM011132
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can a VR headset help you overcome social anxiety?
Symptom relief Recruiting nowThe purpose of this study is to test mechanisms and processes of virtual reality and augmented reality exposure therapy for social anxiety. There is substantial evidence that virtual reality exposure therapy is an effective treatment for social anxiety. However, it can be difficu…
Phase: NA • Sponsor: Palo Alto University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Could a tiny ear device ease cancer survivors' pain?
Symptom relief Recruiting now1. To evaluate the feasibility and acceptability of a home-based taVNS intervention and follow-up for pain and symptom management in breast cancer survivors. 2. To investigate the impact of taVNS on secondary outcomes, including pain, anxiety, depression, fatigue, and the brain-g…
Phase: NA • Sponsor: Florida State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New drug aims to ease discomfort for ventilator patients in ICU
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of Tegileridine Fumarate lnjection for prolonged abirritation(48h to 72h) during mechanical ventilation in the ICU.
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New balloon treatment aims to keep leg arteries open longer
Disease control Not yet recruitingThe purpose of this study is to evaluate the long-term safety and efficacy of GENOSS PCB in patients with long femoropopliteal lesions who underwent percutaneous transluminal angioplasty using GENOSS PCB.
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC